James van der Beek on Warning Signs for Colorectal Cancer

James van der Beek has opened up about the subtle symptoms of colorectal cancer that he overlooked before receiving a shocking diagnosis.

“There wasn’t any glaring red flag,” he noted in a recent conversation. The actor, known for his role in Dawson’s Creek, revealed his diagnosis last November.

“Honestly, I wasn’t very informed about colorectal cancer. I hadn’t realized that the recommended screening age had dropped to 45; I just kept thinking I had time since I was still in my 50s,” he shared.

A colonoscopy ultimately confirmed that van der Beek had stage 3 colon cancer.

Even as the number of diagnoses among older adults declines, cases of colon cancer in younger individuals have been consistently increasing over the last three decades. In 2019, about 20% of colorectal cancer cases were found in people under 55, compared to just 11% in 1995.

Before being diagnosed, van der Beek noticed a change in his bowel habits. He recalled thinking perhaps he just needed to cut back on coffee. “I wondered if it was that or maybe just not adding cream,” he said. “But when the changes persisted, I thought, okay, I should probably get this checked out.”

Recognizing Symptoms of Colorectal Cancer

Shifts in bowel movements are among several classic signs of colorectal cancer. Experts explain that tumors can lead to various bathroom issues, essentially “blocking the pipe.” This could manifest as constipation, diarrhea, or a combination of both. Patients might also feel incomplete after a bowel movement or notice changes in the appearance of their stool.

Another condition often seen in colon cancer patients is pencil-thin stools, which may occur when a tumor affects the area around the intestine, making it narrower.

Other symptoms to watch for include fatigue, unexplained weight loss, anemia, abdominal pain, and rectal bleeding. Colorectal cancer is the third most common cancer in the U.S., and cases of early-onset cancer are increasing; projections suggest that diagnoses among people under 50 will double by 2030.

Van der Beek’s Message About Cancer Awareness

In light of his experience, van der Beek has teamed up with Guardant Health to promote awareness regarding Shield’s blood tests for cancer detection.

“What I appreciate about the Shield test is its convenience; it’s simple and approved by the FDA. You can easily do it during your next doctor’s appointment,” he explained.

While colonoscopy is the standard procedure for detecting colorectal cancer, blood tests like Shield offer alternatives for early detection.

Van der Beek emphasized that a simple blood draw might encourage more people to get screened. “After all, not everyone can take time off work for a colonoscopy,” he pointed out.

According to the FDA, a study indicated that the Guardant Shield test successfully detected about 83% of colorectal cancers.

“I really want to stress that you don’t need to have symptoms to be screened. If you’re over 45 or have a family history, please talk to your doctor about your options,” he advised.

The Colon Cancer Alliance reports that 82% of young colon cancer survivors were misdiagnosed initially, and many consulted multiple doctors before getting the correct diagnosis.

Early detection significantly raises survival rates. Mortality rates from colon cancer for individuals under 55 have increased by about 1% annually since the mid-2000s. In contrast, deaths among older populations have dropped, as cancers in younger people often reach more advanced stages before detection.

On the topic of prevention and early diagnosis, van der Beek remarked, “This has been a significant part of my healing journey, and I feel compelled to share my experience to help others facing similar challenges.”